Table 3.

Study outcome evaluation.

Endpoint	SOC Group	LUS Group	Relative Risk	p Value
Admission due to ADHF	4 (10.8%)	8 (19%)	1.9 (0.53–7.06)	0.3
ED visit due to ADHF	0 (0%)	1 (2.3%)	1.96 (1.56–2.43)	0.33
Furosemide at HD	5 (13.5%)	0 (0%)	0.4 (0.33–0.56)	0.019
Death due to ADHF	2 (5.4%)	2 (4.7%)	0.87 (0.11–6.54)	0.89
Composite endpoint	11 (29.7%)	11 (26.1%)	0.83 (0.31–2.24)	0.72

Legend: LUS: lung ultrasound; SOC: standard of care management group; ADHF: acute decompensated heart failure; HD: hospital discharge.